2-(1-(tert-Butoxycarbonyl)azetidin-3-yl)acetic acid, 95.0%, 5g

(R)-2-(4-(Trifluoromethyl)benzyl)pyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 250mg

4-Chloro-6-(4-methoxy-phenyl)-thieno[3,2-d]-pyrimidine, 5g

Methyl 2-hydroxy-4-(trifluoromethyl)benzoate, 97%, 100g

(4-(Prop-1-en-2-yl)cyclohex-1-en-1-yl)methanol, 89.0%, 500g

Molybdenum foil 99.95% 0.5 x 100 x 200 mm 1 pc

tert-Butyl 3-(2-hydroxypropan-2-yl)pyrrolidine-1-carboxylate, 97%, 5g

2-Bromo-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one, 97%, 250mg

6-Chloro-2-methyl-5-nitro-2H-indazole, 97%, 1g

3'-Methoxy-biphenyl-4-sulfonyl chloride, 95.0%, 1g

1,5-Naphthyridin-2-amine, 98%, 1g

6-Bromo-3,4-dihydro-4,4-dimethylquinolin-2(1H)-one, 95.0%, 1g

Sulfamic acid, [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-[(trifluoromethyl)thio]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl ester, 50mg